Analyst Ratings for Integra LifeSciences (IART) [Buys]
IART Rating Summary
IART Price Target Summary
- Highest: $52.00 (Jefferies)
- Lowest: $37.00 (Morgan Stanley)
- Average: $42.89
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$42.89 (+46%)
* Over Last 12-Mos
Rating Score: 3.8 / 10
Percentile Rank: 36%
Avg. $ Target:
$42.89 (+46%)
* Over Last 12-Mos
Rating Score: 3.8 / 10
Percentile Rank: 36%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 12/5/2023 | Wells Fargo » Updated 2/29/2024 |
Vik Chopra | Upgrade | Overweight (Equal Weight) |
45.00 (49.00) |
40.38 (29.38) |
-27.24% | Details |
| 11/14/2023 | CL King | Kristen Stewart | New Coverage | Buy (N/A) |
50.00 (N/A) |
36.60 (29.38) |
-19.73% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
